Icon

Time Sensitive

Ordering Recommendation

Use to diagnose Bernard-Soulier syndrome or Glanzmann thrombasthenia in patients with a lifelong history of platelet-type bleeding.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (EDTA), pink (K2 EDTA), or yellow (ACD Solution B).

Specimen Preparation

Transport 4 mL whole blood. (Min: 0.1 mL)

Storage/Transport Temperature

Room temperature.

Unacceptable Conditions
Remarks
Stability

EDTA: Ambient: 72 hours; Refrigerated: 72 hours; Frozen: Unacceptable
ACD solution B: Ambient: 72 hours; Refrigerated: Unacceptable; Frozen: Unacceptable

Methodology

Qualitative Flow Cytometry

Performed

Sun-Sat

Reported

1-3 days

Reference Interval

Normal

Interpretive Data

Refer to report.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

86022 x3

Components

Component Test Code* Component Chart Name LOINC
2013071 GPIb (CD42b) Expression
2013072 GPIIb/IIIa (CD41/CD61) Expression
2013073 Platelet Glycoprotein Expression Interp
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Bernard-Soulier Syndrome
  • CD41
  • CD42b
  • CD61
  • Glanzmann Thrombasthenia
  • GPIb
  • GPIIb/IIIb
  • PGE
Platelet Surface Glycoprotein Expression (PGE) by Flow Cytometry, Whole Blood